New Drug Application for ziftomenib in adults with R/R NPM1-m AML remains under FDA Priority Review, with a PDUFA target action date of ...
Get Q3 2025 insights on Realty Income’s investment strategy, AI-driven growth, and European expansion. Learn how O delivers resilient income.
Detailed price information for Composecure Inc (CMPO-N) from The Globe and Mail including charting and trades.
Detailed price information for Composecure Inc (CMPO-N) from The Globe and Mail including charting and trades.
As a Kenvue Inc. ( KVUE) shareholder, the core question is whether the proposed acquisition by Kimberly-Clark Corporation ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback